Literature DB >> 26633952

Limiting Retinal Toxicity of Vigabatrin in Children With Infantile Spasms.

Prakash Kotagal.   

Abstract

Entities:  

Year:  2015        PMID： 26633952      PMCID： PMC4657771          DOI： 10.5698/1535-7511-15.6.327

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  15 in total

1.  Evidence-based guideline update: medical treatment of infantile spasms. Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.

Authors:  C Y Go; M T Mackay; S K Weiss; D Stephens; T Adams-Webber; S Ashwal; O C Snead
Journal:  Neurology       Date:  2012-06-12       Impact factor: 9.910

2.  Visual field defects associated with vigabatrin therapy.

Authors:  M C Lawden; T Eke; C Degg; G F Harding; J M Wild
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-12       Impact factor: 10.154

Review 3.  Vigabatrin-associated retinal damage: potential biochemical mechanisms.

Authors:  M K Heim; B E Gidal
Journal:  Acta Neurol Scand       Date:  2012-05-26       Impact factor: 3.209

4.  Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis.

Authors:  C Chiron; C Dumas; I Jambaqué; J Mumford; O Dulac
Journal:  Epilepsy Res       Date:  1997-01       Impact factor: 3.045

5.  Retinal nerve fiber layer thickness in vigabatrin-exposed patients.

Authors:  Lisa M Clayton; Marita Dévilé; Trusjen Punte; Constantinos Kallis; Gerrit-Jan de Haan; Josemir W Sander; James Acheson; Sanjay M Sisodiya
Journal:  Ann Neurol       Date:  2011-01-19       Impact factor: 10.422

Review 6.  Vigabatrin: 2008 update.

Authors:  L James Willmore; Mark B Abelson; Elinor Ben-Menachem; John M Pellock; W Donald Shields
Journal:  Epilepsia       Date:  2009-02       Impact factor: 5.864

7.  Vigabatrin retinopathy in an Irish cohort: lack of correlation with dose.

Authors:  Peter Kinirons; Gianpiero L Cavalleri; Dierdre O'Rourke; Colin P Doherty; Irene Reid; Patricia Logan; Brenda Liggan; Norman Delanty
Journal:  Epilepsia       Date:  2006-02       Impact factor: 5.864

8.  Visual fields in young children treated with vigabatrin.

Authors:  Shivi Agrawal; D Luisa Mayer; Ronald M Hansen; Anne B Fulton
Journal:  Optom Vis Sci       Date:  2009-06       Impact factor: 1.973

9.  Taurine deficiency is a cause of vigabatrin-induced retinal phototoxicity.

Authors:  Firas Jammoul; Qingping Wang; Rima Nabbout; Caroline Coriat; Agnès Duboc; Manuel Simonutti; Elisabeth Dubus; Cheryl M Craft; Wen Ye; Stephen D Collins; Olivier Dulac; Catherine Chiron; José A Sahel; Serge Picaud
Journal:  Ann Neurol       Date:  2009-01       Impact factor: 10.422

10.  Vigabatrin retinal toxicity in children with infantile spasms: An observational cohort study.

Authors:  Carol A Westall; Tom Wright; Filomeno Cortese; Ananthavalli Kumarappah; O Carter Snead; Joseph R Buncic
Journal:  Neurology       Date:  2014-11-07       Impact factor: 9.910
View more
  1 in total

Review 1.  An Update on the Ophthalmologic Features in the Phakomatoses.

Authors:  Solmaz Abdolrahimzadeh; Andrea Maria Plateroti; Santi Maria Recupero; Alessandro Lambiase
Journal:  J Ophthalmol       Date:  2016-07-17       Impact factor: 1.909
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.